文献速递肿瘤 PET/CT心脏核医学

房间隔脂肪瘤样肥厚中PSMA摄取偶然检出的解读

Incidental Detection of PSMA Uptake in Lipomatous Hypertrophy of the Interatrial Septum.
PubMed 文献 · Clin Nucl Med · 2026-06-05

本文报道一例在18F-Piflufolastat(18F-DCFPyL)PET/CT中,房间隔脂肪瘤样肥厚(LHIS)显示PSMA活性摄取。LHIS为良性、通常偶然发现且无症状的病变,在FDG PET/CT上已知可有摄取。这是PSMA PET/CT判读中的潜在陷阱,不应与恶性心脏肿块混淆,认识该活性来源可避免不必要的干预或额外影像检查。

要点

  • LHIS可在PSMA PET/CT上显示摄取,属良性偶然发现。
  • 勿将LHIS的PSMA摄取误判为恶性心脏肿块。
  • 认识该活性来源可避免不必要的干预或额外影像。

核心结论

  • LHIS在PSMA PET/CT上可表现为PSMA活性摄取,是判读中的潜在陷阱,不应与恶性心脏肿块混淆。

研究设计与样本

  • 本文为单病例报告,描述一例18F-Piflufolastat(18F-DCFPyL)PET/CT中偶然检出LHIS PSMA摄取的病例。

主要发现

  • 该病例显示LHIS相关PSMA活性,LHIS为良性、通常偶然发现且无症状的病变,在FDG PET/CT上已知有摄取。

临床怎么用

  • 判读PSMA PET/CT时认识LHIS可摄取PSMA,避免将其误判为恶性心脏肿块,从而避免不必要的干预或额外影像检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PET/CT with 18 F-Piflufolastat ( 18 F-DCFPyL, trade name Pylarify) is performed to identify areas of metastatic prostate cancer. However, activity is seen in many additional organs and benign conditions. This case illustrates PSMA activity associated with lipomatous hypertrophy of the interatrial septum (LHIS), a benign, usually incidental and asymptomatic lesion with well-known uptake on FDG PET/CT. This is a potential pitfall in the interpretation of PSMA PET/CT, which should not be confused with a malignant cardiac mass. Awareness of this source of activity avoids unnecessary intervention or additional imaging.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. DeSai C, Salem AE, Surasi DSS, et al. Incidental Detection of PSMA Uptake in Lipomatous Hypertrophy of the Interatrial Septum. Clin Nucl Med. 2026. PMID: 42257561. doi:10.1097/RLU.0000000000006460

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。